News

One of the University of Kentucky Markey Cancer Center’s leading researchers has been selected to participate in the inaugural cohort of the National Institutes of Health (NIH) funded Institutional Development Award (IDeA) Regional Entrepreneurship Development (I-RED) Program.

The University of Kentucky will be home to a new research center focused on tobacco regulations in the Commonwealth named the Appalachian Tobacco Regulatory Science Team (AppalTRuST).

Launched in 2016, ACTION is a cancer education and training program aimed at high school and undergraduate students from Appalachian Kentucky.

Collaborations with community hospitals across Kentucky give cancer patients access to the latest treatments and clinical trials closer to home.

The University of Kentucky Markey Cancer Center announced today that it has earned a National Cancer Institute “Comprehensive” Cancer Center designation, the highest level of recognition awarded by the NCI.

While cancer survivors have an increased risk of developing cancer in the future, that risk is notably higher in Kentucky and Appalachian Kentucky, according to a new University of Kentucky Markey Cancer Center study.

Using antibodies derived from alpacas, a University of Kentucky research team has developed a tool that could lead to new therapies to stop the growth of several types of cancer.

The inaugural cohort of President Biden’s Cancer Moonshot Scholars includes University of Kentucky Markey Cancer Center researcher Laurie McLouth, Ph.D.

Markey researcher Ren Xu, Ph.D., received a $2 million grant from the NCI to support his research on the role of platelets in cancer metastasis.

A Markey Cancer Center research team identified an existing cancer drug that shows promise as a treatment for the most common type of non-small cell lung cancer.